SEBI Bars Seven Family Members in Social Media Stock PumpandDump Case Alleges 2025 Crore Illegal Gains
Vickers Stock Research Releases Top Insider Picks for May 26 2026
Compass COMP Stock Under 15 Market Perspectives and Key Considerations
Krispy Kreme 16M Data Breach Settlement Deadline Approaches Who Is Eligible
Gold Prices Dip as Feds Waller Flags Potential Rate Hike Amid Iran Energy Shock
Intel Urges PC Makers to Embrace Advanced 18A Processors as AIDriven Semiconductor Demand Surges
ROP Q1 2026 Earnings EPS Beat Driven by Operational Strength Amid Modest Market Response
HYPD Q1 2026 Earnings Significant EPS Miss Sends Shares Lower
AWK Q1 2026 Earnings EPS Falls Short Shares Slip Slightly
QLYS Q1 2026 Earnings EPS Surpasses Estimates by 62 Despite Slight Stock Decline
MDGL Q1 2026 Earnings Narrower Loss Surpasses Expectations Amid No Revenue Reported
SOJE Q1 2026 Earnings Southern Company Beats EPS Estimates as Utility Operations Remain Stable
NewtekOne Inc NEWT Edges Higher as Shares Approach Resistance Zone
Great Elm Group Notes GEGGL Steady at 2454 as FixedIncome Investors Seek Yield
Calisa Acquisition Corp Right ALISR Holds Steady at 056 as Support and Resistance Levels Tighten
NanoViricides NNVC Surges 136 as Stock Approaches Key Resistance
Xencor Inc XNCR Holds Near Support as Biotech Sector Shows Mixed Signals
Lucid Motors Speculated as Potential Robotaxi Player
TAK Q1 2026 Earnings NarrowerthanExpected Loss as EPS Surprises Positively
Broadridge Financial Solutions BR Holds Steady Near 147 as Consolidation Continues
Freedom Holding Corp FRHC Q1 2026 Earnings Solid EPS Reported Amid Quiet Disclosure Shares Slip
Nathans Famous Q4 2024 Earnings EPS of 096 Reported Stock Edges Lower
IRIX Q1 2026 Earnings NarrowerthanExpected Loss Signals Operational Discipline
SAQ Q1 2026 Earnings Steep EPS Miss Clouds Outlook for BDC
BZAI Q1 2026 Earnings NarrowerthanExpected Loss EPS Beat Signals Operational Progress
BLX Q1 2026 Earnings Solid EPS Performance Amid Market Volatility
Ernexa Therapeutics ERNA Q3 2023 Earnings Deepening Losses and ClinicalPhase Uncertainty Weigh on Shares